REGENXBIO Inc. is celebrating the opening of its new Manufacturing Innovation Center gene therapy manufacturing facility.
Also Read: Updated Data for Janssen’s Bispecific Teclistamab Suggest...
CyanVac LLC, a clinical-stage biopharmaceutical company developing intranasal vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector, announced preclinical data in a hamster...
KP Performance Antennas, an Infinite Electronics brand and a manufacturer of wireless network antennas, has just introduced a new series of wide-band, log periodic,...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced updated efficacy and safety results from the teclistamab Phase 1/2 MajesTEC-1 study.1 Teclistamab is an...
athenahealth, Inc., a leading provider of network-enabled software and services for medical groups and health systems nationwide, and Smile Foundation today announced that through...
